Abiopharma

News list

📋 GOLDSMITH MARK A (Officer) plans to sell 13K shares of Revolution Medicines, Inc. (at $99.59 each, total $1.3M) Filed: Mar 13, 2026 | ID: 000001

Full text

News bot March 13, 2026, 11:34 p.m.
📋 Form 144 Filing: GOLDSMITH MARK A

Company: Revolution Medicines, Inc.

Filing Date: 2026-03-13

Relationship: Officer; Director
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 13,261
- Price per Share: $99.59
- Total Value: $1,320,662.99
- Planned Sale Date: 2026-03-16
- Broker: ETRADE Financial Corporation
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-39219
- Issuer Contact Phone: 650-481-6801
- Issuer Address: 700 SAGINAW DR, REDWOOD CITY, CA, 94063
- Broker Address: 3 Edison Drive, Alpharetta, GA, 30005
- Shares Outstanding: 198173397.0
- Number of Securities to be Sold: 4
- Number of Past Sales: 4
- Signature: /s/ Jack Anders, as Attorney-in-fact for Mark A. Goldsmith